 |
 |
 |
|
 |
|
|
 |
Faculty
 |
Stephen M. Sammut Senior Fellow and Lecturer, Wharton Health Care Systems Venture Partner, Burrill & Company
Courses Health Care Systems: Seminar on the Private Sector Role in Global Health Management 809: Private Equity in Emerging Markets Management 804: Venture Capital and Entrepreneurial Management
Biography Stephen M. Sammut currently holds an appointment as Senior Fellow and Lecturer, Wharton Health Care Systems. Within Health Care Systems, he conducts a seminar on the role of the private sector in global health. This seminar is linked to research underway – in collaboration with the McLaughlin-Rotman Center for Global Health at the University of Toronto – that is studying the capacity of countries such as India, China, South Africa, and Brazil to develop indigenous pharmaceutical and biotechnology industries. The project is funded by the Bill & Melinda Gates Foundation. Mr. Sammut also teaches in Wharton Entrepreneurial Programs, he teaches MGMT 809: Private Equity in Emerging Markets. Mr. Sammut also conducts independent studies with students on private equity, business plan development, and private enterprise creation in the developing world.
Mr. Sammut periodically teaches in the School of Engineering and Applied Science, the Law School and the Medical School of the University of Pennsylvania. His courses in those venues and at Wharton include: health care related entrepreneurship, venture capital and private equity securities, mergers and acquisitions for technology companies, and intellectual property strategy. His other academic activity includes research on biotechnology company business models and resource optimization, FDA drug development optimization, and health equity in the developing world. Mr. Sammut is a faculty liaison for Wharton Healthcare International Volunteers, a student group that supports care management needs at clinics in several developing countries.
Outside of Wharton, Mr. Sammut is Venture Partner, Burrill & Company, a merchant bank and venture capital fund focused on the life sciences. His role there is general management of overseas venture capital funds, particularly in the Asia-Pacific region.
During his private sector career, Mr. Sammut has been involved in the creation or funding of nearly 40 biotechnology, Internet, and information technology companies globally. He is on numerous Boards of Directors including Doctors of the World, the Center for Medicine in the Public Interest, Dynamis Therapeutics, Combinent BioMedical Systems, and serves as a senior advisor to Mitsubishi Corporation’s Life Science Business Unit, the ethics advisory board to the life sciences group of the International Finance Corporation, the Royal Bank of Canada Strategic Technology Fund, the Cornell Research Foundation, Zad (a Mid Eastern venture capital fund), and the Asia-Pacific Fund. He is on the publications board of the European venture Capital Association.
Mr. Sammut is founder and chair of the International Institute for Biotechnology Entrepreneurship, a non-profit organization that offers intensive training programs throughout the world. These “Boot Camps” focus on the essentials of company formation and advanced management skills in life science companies. He is also a faculty member of the World Intellectual Property Organization (a UN agency) Academy where he teaches intellectual property strategy. He created and chaired the Association of University Technology Manager’s startup business development course for many years. He lectures extensively and biotechnology and global health conferences.
Mr. Sammut previously held the positions of Vice President of Development of Teleflex Incorporated and Vice President, S.R.One, Ltd., GlaxoSmithKline’s venture fund. During his career he was Managing Director of the Center for Technology Transfer at the University of Pennsylvania, and held a similar position at Thomas Jefferson University. At the start of his career, Mr. Sammut co-founded and served as CEO of the Delaware Valley Organ Transplant Program over an eight year period building it into one of the largest organ banks in the world.
He holds graduate and undergraduate degrees from Villanova University in biological sciences and philosophy, attended Hahnemann Medical College for two years, and holds an MBA from the Wharton School.
Representative Recent Publications
|
